International journal of rheumatic diseases, vol.21, no.8, pp.1557-1562, 2018 (Journal Indexed in SCI Expanded)
Article / Article
Title of Journal :
International journal of rheumatic diseases
methotrexate, methotrexate toxicity, renal insufficiency, LOW-DOSE METHOTREXATE, RHEUMATOID-ARTHRITIS, ACID SUPPLEMENTATION, INDUCED PANCYTOPENIA, FOLINIC ACID, TOXICITY, THERAPY
Aim: Methotrexate (MTX) is the first-line disease-modifying antirheumatic drug in rheumatoid arthritis (RA). However, this anchor may cause some side effects that may range from nausea to mortality. The clinical features of MTX toxicity are under-researched. In this study, we aimed to find out the potential predisposing factors and outcomes of the MTX toxicity (n = 31).